BiologicsCreate better biologic treatments and speed your path to market with our range of advanced technologies and services. Learn More Catalent to Acquire Manufacturing Facility from Bone TherapeuticsExpanding its industry-leading cell therapy capabilities and advanced clinical and commercial supply in Belgium Learn More Catalent Partnering with Multiple Customers on COVID-Related Vaccines and TherapiesIncluding Johnson & Johnson, AstraZeneca, Moderna and Humanigen Learn More Developing Biologic Drugs is Science.Accelerating Advanced Treatments & Vaccines is Art. Learn More Expertise Across Various Cell TypesOur comprehensive cell therapy portfolio spans a wide range of cell types including CAR-T, TCR, TILs, and more Learn More BiologicsCreate better biologic treatments and speed your path to market with our range of advanced technologies and services. Learn More Catalent to Acquire Manufacturing Facility from Bone TherapeuticsExpanding its industry-leading cell therapy capabilities and advanced clinical and commercial supply in Belgium Learn More Catalent Partnering with Multiple Customers on COVID-Related Vaccines and TherapiesIncluding Johnson & Johnson, AstraZeneca, Moderna and Humanigen Learn More Developing Biologic Drugs is Science.Accelerating Advanced Treatments & Vaccines is Art. Learn More Expertise Across Various Cell TypesOur comprehensive cell therapy portfolio spans a wide range of cell types including CAR-T, TCR, TILs, more Learn More How can we work together BiologicsDevelopment Gene Therapy Cell Therapy Technologies Latest News Catalent to Acquire Cell Therapy Manufacturing Facility from Bone Therapeutics CATALENT RESPONDS TO THE GLOBAL COVID-19 OUTBREAK We are taking decisive action to minimize the impact of the COVID-19 pandemic on our employees, partners, customers, and their patients. LEARN MORE Cell Therapy With our advanced technologies and expertise in both autologous and allogeneic development and manufacturing, Catalent is your full-service partner for CAR-T immunotherapies and beyond. Gene Therapy With experience across more than 60 gene therapy programs and leading expertise in AAV Vectors, Catalent’s Gene Therapy team will provide you with full life cycle support of your life-saving therapeutic. STRATEGIES TO ACHIEVE SUCCESSFUL COMMERCIAL APPROVAL & LAUNCH Experts share how scale-up, regulatory expectations, demand forecasting and process validation all play a role in the successful launch and approval of a biologic. Biologics Network Our network of biologics sites provides an integrated approach to get medicines to your patients faster anywhere in the world. SEE ALL LOCATIONS Join Our Team Catalent is growing in Biologics and is making significant investments in people in this area. Explore global career opportunities with our Biologics team. NEWS Catalent to Acquire Cell Therapy Manufacturing Facility from Bone Therapeutics Catalent and BrainStorm Cell Therapeutics Announce Partnership for the Manufacture of Mesenchymal Stem Cell Platform Therapy NurOwn® Catalent to Discuss Innovative Approaches to Achieving T-Cell Commercial Readiness at Upcoming Industry Conference Innovation in Oncology, Cell & Gene Technology, and Post-COVID-19 Pharma Outlook to be Discussed by Catalent at CPhI VIEW ALL NEWS EVENTS Gene Therapy for Rare Disorders ISOBiotech Spring Meeting Cell Culture Engineering XVII Interphex VIEW ALL EVENTS EXPERT CONTENT Advances in Analytical Technology for Biopharmaceuticals Prefilled Syringes & Parental Manufacturing Accelerating Method Transfer: Effective Automation Of Biological Assays VIEW ALL ARTICLES
